• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH131002W
Device Problem Material Fragmentation (1261)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/06/2021
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing records indicated the device met pre-release specifications.Complete section additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2021, a patient was implanted with a 13mm x 10cm gore® viabahn® endoprosthesis with heparin bioactive surface(viabahn device) to treat central vein stenosis.The physician deployed the viabahn device.During the deployment, the deployment line broke into filaments in sheath.After checking the images, it was found the distal stent was expanded and the proximal end didn't expand (half of the stent didn't expand).The physician waited for about one minute and found the proximal end expanded on the images, then performed post dilation.The procedure was completed and the patient tolerated the procedure.The position of stent was slightly away with ideal position.The second endovascular procedure will be planned if necessary.
 
Manufacturer Narrative
Imaging evaluation summary: the images received cannot be used to perform a full imaging evaluation because they do not meet the dicom standard.The extent and accuracy of the observations and findings may be limited due to the completeness, format and/or quality of the images provided for review.Gore cannot guarantee the images provided are complete, accurate or lack alteration.Therefore, gore cannot guarantee all key findings have been captured or that the findings are accurate.Five images (jpegs) submitted for evaluation, only 2 of the images are x-rays, shown below.The image(s) received cannot be used to perform an imaging evaluation due to the insufficient data and/or poor quality of the image(s) provided.Images provided do not allow for evaluation in relationship to this event.Engineering evaluation: the manufacturing records were reviewed, and the device lot met all pre-release specifications.Evaluation of the returned product confirms the deployment line is broken.The deployment knob was also found broken, but the cause of the broken deployment knob could not be established.The delivery catheter was returned without the endoprosthesis.The deployment knob is broken.The deployment line is still attached to the deployment knob.The deployment line is broken 46 cm from the knob.An additional 133cm of deployment line was returned.There are several individual deployment line fibers extending at the break location.The zipper is fully deployed.Dual lumen: appears unremarkable.Distal shaft: appears unremarkable.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12757709
MDR Text Key281520627
Report Number2017233-2021-02516
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeTW
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/27/2024
Device Catalogue NumberVBH131002W
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/12/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SJM FAST CATH SHEATH 12 FR. 12CM
Patient Age66 YR
Patient SexMale
-
-